by The global computer-aided drug discovery market size accounted for US$ 3.36 Bn in 2022 and is projected to reach around USD 10.44 Bn by 2032, growing at a CAGR of 12% from 2023 to 2032.
Report Summary
The global computer-aided drug discovery market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the computer-aided drug discovery market across the globe.
A comprehensive estimate on the computer-aided drug discovery market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of computer-aided drug discovery during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2965
Computer-Aided Drug Discovery Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 3.76 Billion |
| Market Size by 2032 | USD 10.44 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 12% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Type, By Therapeutic Area, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized computer-aided drug discovery market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Prostate Cancer Market Size To Cross USD 28.37 Bn By 2032
Computer-Aided Drug Discovery Market Players
The report includes the profiles of key computer-aided drug discovery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area
- Albany Molecular Research Inc. (AMRI)
- BOCSCI Inc.
- AstraZeneca
- Bioduro-Sundia
- Schrödinger, Inc.
- Bayer AG
- Aragen Life Sciences Pvt. Ltd.
- Charles River Laboratories
- Aris Pharmaceuticals
- Albany Molecular Research Inc.
Market Segmentation
By Type
- Structure-based Drug Design
- Ligand-based Drug Design
- Sequence-based Approaches
By Therapeutic Area
- Oncology
- Neurology
- Cardiovascular diseases
- Respiratory diseases
- Diabetes
By End User
- Pharmaceuticals companies
- Biotechnology companies
- Research Laboratories
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Computer-Aided Drug Discovery Market
5.1. COVID-19 Landscape: Computer-Aided Drug Discovery Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Computer-Aided Drug Discovery Market, By Type
8.1. Computer-Aided Drug Discovery Market Revenue and Volume, by Type, 2023-2032
8.1.1 Structure-based Drug Design
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Ligand-based Drug Design
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Sequence-based Approaches
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Computer-Aided Drug Discovery Market, By Therapeutic Area
9.1. Computer-Aided Drug Discovery Market Revenue and Volume, by Therapeutic Area, 2023-2032
9.1.1. Oncology
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Neurology
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Cardiovascular diseases
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
9.1.4. Respiratory diseases
9.1.4.1. Market Revenue and Volume Forecast (2020-2032)
9.1.5. Diabetes
9.1.5.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Computer-Aided Drug Discovery Market, By End User
10.1. Computer-Aided Drug Discovery Market Revenue and Volume, by March, 2023-2032
10.1.1. Pharmaceuticals companies
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Biotechnology companies
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Research Laboratories
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Computer-Aided Drug Discovery Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.1.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.1.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.1.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.1.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.1.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.1.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.2.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.2.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.2.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.2.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.2.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.2.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.2.6.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.2.6.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.2.7.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.2.7.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.3.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.3.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.3.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.3.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.3.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.3.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.3.6.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.3.6.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.3.7.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.3.7.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.4.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.4.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.4.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.4.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.4.6.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.4.6.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.4.7.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.4.7.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.5.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.5.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.5.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.5.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)
Chapter 12. Company Profiles
12.1. Albany Molecular Research Inc. (AMRI)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BOCSCI Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. AstraZeneca
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Bioduro-Sundia
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Schrödinger, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Bayer AG
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Aragen Life Sciences Pvt. Ltd.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Charles River Laboratories
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Aris Pharmaceuticals
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Albany Molecular Research Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
